Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma"), announced today that it intends to offer its ordinary shares in an underwritten public offering.
Shares of Theravance Biopharma were down almost 10% in after-hours trading on Thursday after the company disclosed plans for a public offering of its common stock, as reported by Fidelity.